Live Breaking News & Updates on Quentin Ansteecoordinator

The FINANCIAL The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study will follow 200 patients with cirrhosis – scarring caused by long-term damage of the liver – to uncover why some patients experience liver failure or develop liver cancer. Researchers from the Universities of Edinburgh and Newcastle hope their findings will lead to earlierThe FINANCIAL The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study will follow 200 patients with cirrhosis – scarring caused by long-term damage of the liver – to uncover why some patients experience liver failure or develop liver cancer. Researchers from the Universities of Edinburgh and Newcastle hope their findings will lead to earlier » The FINANCIAL Health&Beauty ....

Quentin Ansteecoordinator , Boehringer Ingelheim , Professor Of Experimental Hepatology At Newcastle University , Foundation Trustnone , University Of Edinburgh , University Of Edinburghnone , Accelerating Discovery , Neil Hendersonco Lead , Tissue Repair , Experimental Hepatology , Newcastle University , Consultant Hepatologist , Newcastle Hospitals , Health Amp Beauty ,